The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly
NCT00117000 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2006-09-11
Summary
The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women.
Conditions
- Malnutrition
- Aging
Interventions
- DRUG
-
testosterone undecanoate
Sponsors & Collaborators
-
Organon
collaborator INDUSTRY -
University of Adelaide
lead OTHER
Principal Investigators
-
Ian M Chapman, MBBS, PhD · University of Adelaide
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Completion
- 2007-02-28
Countries
- Australia
Study Locations
More Related Trials
-
Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents
NCT02679274 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
NCT04049331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
NCT03716739 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00104572 ·Status: COMPLETED ·Phase: PHASE2
-
Study of The Effects of Testosterone in Frail Elderly Men
NCT00190060 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency
NCT00161304 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Testosterone Supplementation on Rehabilitation Outcomes
NCT00037999 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Administration and ACL Reconstruction in Men
NCT01595581 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
NCT04301765 ·Status: RECRUITING ·Phase: PHASE2
-
Vitamin D Treatment and Hypogonadism in Men
NCT01748370 ·Status: COMPLETED ·Phase: PHASE4
-
Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life
NCT07143279 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Trial of Testosterone Undecanoate
NCT01765179 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy
NCT01816295 ·Status: COMPLETED ·Phase: PHASE3
-
The Testosterone Trials in Older Men
NCT00799617 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
NCT04731376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Effect of Testosterone Replacement on Bone Mineral Density in Boys and Men With Anorexia Nervosa
NCT00853502 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
NCT01724658 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Replacement in Older Men and Atherosclerosis Progression
NCT00287586 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Testosterone for the Treatment of Hypogonadism
NCT01717768 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone and Major Depression
NCT00286546 ·Status: COMPLETED
-
Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)
NCT00239590 ·Status: COMPLETED ·Phase: PHASE2
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
Testosterone Therapy in Hypogonadal Men Treated With Opioids
NCT02433730 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
NCT00467870 ·Status: COMPLETED ·Phase: PHASE3